PDS Biotechnology Corp Preferred Stock, Shares Authorized
PDS Biotechnology Corp (PDSB) had Preferred Stock, Shares Authorized of 5.00 million shares as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-03-30
- 2025-12-31: Preferred Stock, Shares Authorized 5.00M shares.
- 2024-12-31: Preferred Stock, Shares Authorized 5.00M shares.
- 2023-12-31: Preferred Stock, Shares Authorized 5.00M shares.
- 2022-12-31: Preferred Stock, Shares Authorized 5.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2025-12-31 | 5.00M shares 10-K · filed 2026-03-30 |
| 2024-12-31 | 5.00M shares 10-K · filed 2025-03-27 |
| 2023-12-31 | 5.00M shares 10-K · filed 2024-03-28 |
| 2022-12-31 | 5.00M shares 10-K · filed 2023-03-28 |
| 2021-12-31 | 5.00M shares 10-K · filed 2022-03-31 |
| 2020-12-31 | 5.00M shares 10-K · filed 2021-03-18 |
| 2019-12-31 | 5.00M shares 10-K · filed 2020-03-27 |
| 2019-09-30 | 5.00M shares 10-Q · filed 2019-11-07 |
| 2019-06-30 | 5.00M shares 10-Q · filed 2019-08-01 |
| 2019-03-31 | 5.00M shares 10-Q · filed 2019-05-14 |
| 2018-12-31 | 5.00M shares 10-Q · filed 2019-11-07 |
| 2018-09-30 | 5.00M shares 10-Q · filed 2018-11-01 |
| 2018-06-30 | 5.00M shares 10-Q · filed 2018-08-01 |
| 2018-03-31 | 5.00M shares 10-Q · filed 2018-05-01 |
| 2017-12-31 | 5.00M shares 10-K · filed 2019-02-21 |
| 2017-09-30 | 5.00M shares 10-Q · filed 2017-11-01 |
| 2017-06-30 | 5.00M shares 10-Q · filed 2017-08-01 |
| 2017-03-31 | 5.00M shares 10-Q · filed 2017-05-03 |
| 2016-12-31 | 5.00M shares 10-K · filed 2018-03-01 |
| 2015-12-31 | 5.00M shares 10-K · filed 2017-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |